Lubrizol is a manufacturing company based in the United States, specializing in chemicals and related products. Founded in 1928, the company has grown to employ between 5,001 and 10,000 individuals and generates substantial annual revenue. Lubrizol operates across various sectors, including chemicals, business supplies and equipment, and wholesale retail and consumer goods. The company has published a technical brief focused on polymeric excipients for nasal formulations, highlighting the increasing interest in non-invasive drug delivery methods, particularly nasal administration. This document discusses the critical properties of nasal products, such as mucosal protective barrier functionality, mucoadhesion, and spray pattern, while showcasing case studies that evaluate Lubrizol's Carbopol® polymers in comparison to other common nasal excipients. The brief emphasizes the importance of these properties in developing effective nasal sprays that can protect against respiratory infections, a topic that has gained relevance due to recent global health challenges. Overall, Lubrizol's expertise lies in the formulation and application of advanced chemical solutions within the pharmaceutical sector.